Ocean Biomedical, Inc. (OCEA) Form 10-K Annual Reports
Ocean Biomedical, Inc. (OCEA) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OCEA
CIK: 1869974
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Berkowitz Pollack Brant Advisors + CPAs, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerElizabeth Marks
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| NT 10-Q | 2025-08-14 | 2025-06-30 | NT 10-Q | 0001641172-25-023734 | View SEC Doc Filr Page |
| 25-NSE | 2025-08-08 | — | 25-NSE Filing | 0001354457-25-000798 | View SEC Doc Filr Page |
| 8-K | 2025-08-05 | 2025-07-31 | 8-K | 0001641172-25-022271 | View SEC Doc Filr Page |
| 8-K | 2025-07-23 | 2025-07-17 | 8-K | 0001641172-25-020730 | View SEC Doc Filr Page |
| 8-K | 2025-07-16 | 2025-07-10 | 8-K | 0001641172-25-019924 | View SEC Doc Filr Page |
| 8-K | 2025-06-13 | 2025-06-12 | 8-K | 0001641172-25-015129 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | 10-Q | 0001641172-25-011080 | View SEC Doc Filr Page |
| 10-K/A | 2025-04-29 | 2024-12-31 | ANNUAL REPORT | 0001641172-25-006669 | View SEC Doc Filr Page |
| 8-K | 2025-04-23 | 2025-04-22 | 8-K Filing | 0001641172-25-005788 | View SEC Doc Filr Page |
| 10-K | 2025-04-08 | 2024-12-31 | 10-K Filing | 0001641172-25-003155 | View SEC Doc Filr Page |
| 8-K | 2025-04-01 | 2025-03-28 | 8-K Filing | 0001641172-25-002074 | View SEC Doc Filr Page |
| NT 10-K | 2025-04-01 | 2024-12-31 | NT 10-K Filing | 0001641172-25-002034 | View SEC Doc Filr Page |
| 8-K | 2025-03-26 | 2025-03-26 | 8-K Filing | 0001641172-25-000747 | View SEC Doc Filr Page |
| 8-K | 2025-03-20 | 2025-03-14 | 8-K Filing | 0001493152-25-011046 | View SEC Doc Filr Page |
| DEFA14A | 2025-03-10 | — | DEFA14A Filing | 0001493152-25-009713 | View SEC Doc Filr Page |
| 8-K | 2025-03-10 | 2025-03-04 | 8-K Filing | 0001493152-25-009707 | View SEC Doc Filr Page |
| 8-K | 2025-02-26 | 2025-02-20 | 8-K Filing | 0001493152-25-008395 | View SEC Doc Filr Page |
| DEF 14A | 2025-02-26 | 2025-02-26 | DEF 14A Filing | 0001493152-25-008279 | View SEC Doc Filr Page |
| 8-K | 2025-02-21 | 2025-02-21 | 8-K Filing | 0001493152-25-007933 | View SEC Doc Filr Page |
| PRE 14A | 2025-02-14 | 2025-02-14 | PRE 14A Filing | 0001493152-25-006994 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-02-13 | — | SCHEDULE 13G/A Filing | 0001493152-25-006338 | View SEC Doc Filr Page |
| 8-K | 2025-02-12 | 2025-02-11 | 8-K Filing | 0001493152-25-006180 | View SEC Doc Filr Page |
| 8-K | 2025-01-15 | 2025-01-07 | 8-K Filing | 0001493152-25-002237 | View SEC Doc Filr Page |
| 10-Q | 2025-01-13 | 2024-09-30 | 10-Q Filing | 0001493152-25-001880 | View SEC Doc Filr Page |
| 10-Q | 2024-12-23 | 2024-06-30 | 10-Q Filing | 0001493152-24-051208 | View SEC Doc Filr Page |